Construction of Engineered EcN Bacteria Constitutively Highly Expressing RtSOD/RtSOD-CAT Fusion Protein and its Protective Effect on UC Mice
- PMID: 41484744
- DOI: 10.1007/s12010-025-05536-2
Construction of Engineered EcN Bacteria Constitutively Highly Expressing RtSOD/RtSOD-CAT Fusion Protein and its Protective Effect on UC Mice
Abstract
Superoxide dismutase (SOD) is an antioxidant enzyme containing different metal ion, which can reduce oxidative stress and treat ulcerative colitis (UC). In addition, SOD's therapeutic effect can be enhanced when combined with other antioxidant enzymes, such as catalase (CAT). In this study, the probiotic Escherichia coli Nissle 1917 (EcN) was used as a chassis strain to develop two engineered variants, EcNc-RtSOD and EcNc-MLH. By using two cryptic plasmids, these strains were modified to constitutively express RtSOD and RtSOD-CAT (MLH), respectively. Furthermore, the engineered EcN strains were found to significantly reduce DSS-induced intestinal inflammation and promote intestinal mucosal healing in UC mice.Biochemical analyses revealed that the levels of superoxide dismutase (SOD) and catalase (CAT) in intestinal tissues were significantly elevated, while malondialdehyde (MDA) content was markedly reduced. Compared with the DSS group, the expression level of interleukin-6 (IL-6) in colon tissues of mice treated with RtSOD and MLH decreased by 24.04% and 37.68%, respectively. Similarly, the expression level of interleukin-1β (IL-1β) was reduced by 14.22% and 28.73%, respectively, in the RtSOD and MLH treatment groups compared to the DSS group. This study proposes a novel strategy for UC treatment that utilizes therapeutically engineered bacterial strains.
Keywords: Anti-inflammatory; Catalase (CAT); EcN engineered strain; Superoxide dismutase (SOD); Ulcerative colitis (UC).
© 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: This study met ethical standards regarding the use of laboratory animals, following the protocols outlined by the Experimental Animal Ethics Committee of Zhejiang Sci-Tech University (No. : 20231224-01). Consent for publication: All authors agree to publish the paper in your esteemed journal. Competing interests: The authors declare no competing interests.
References
-
- Bannister, W. H., & Bannister, J. V. (1988). Isolation and characterization of superoxide dismutase: A personal history and tribute to Joe McCord and Irwin Fridovich. Free Radical Biology & Medicine, 5, 371–376. https://doi.org/10.1016/0891-5849(88)90110-4 - DOI
-
- McCord, J. M., & Edeas, M. A. (2005). SOD, oxidative stress and human pathologies: A brief history and a future vision. Biomedicine & Pharmacotherapy(4). https://doi.org/10.1016/j.biopha.2005.03.005
-
- Calvani, N. E. D., De Marco, C. V., Jewhurst, H. L., Cwiklinski, K., Flaus, A., & Dalton, J. P. (2022). Two distinct superoxidase dismutases (SOD) secreted by the helminth parasite fasciola hepatica play roles in defence against metabolic and host immune Cell-Derived reactive oxygen species (ROS) during growth and development. Antioxidants (Basel), 10. https://doi.org/10.3390/antiox11101968
-
- Du, J., Zhu, H., Ye, M.,& Ma, Y., (2019). Macrobrachium rosenbergii Cu/Zn superoxide dismutase (Cu/Zn SOD) expressed in saccharomyces cerevisiae and evaluation of the immune function to vibrio parahaemolyticus. Fish & Shellfish Immunology, 363–375. https://doi.org/10.1016/j.fsi.2019.04.016
-
- Zelko, I. N., Mariani, T. J., & Folz, R. J. (2002). Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radical Biology & Medicine(3). https://doi.org/10.1016/s0891-5849(02)00905-x
LinkOut - more resources
Full Text Sources
Miscellaneous
